X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (36) 36
index medicus (36) 36
infectious diseases (34) 34
female (33) 33
male (33) 33
adult (31) 31
hiv infections - drug therapy (29) 29
immunology (26) 26
antiretroviral therapy (23) 23
hiv (21) 21
human immunodeficiency virus--hiv (21) 21
tuberculosis (21) 21
south africa (18) 18
viral load (16) 16
virology (16) 16
drug therapy (15) 15
cd4 lymphocyte count (14) 14
hiv infections - virology (14) 14
treatment outcome (14) 14
drug resistance (13) 13
middle aged (13) 13
mortality (13) 13
aids/hiv (12) 12
research (12) 12
anti-hiv agents - therapeutic use (11) 11
antiretroviral drugs (11) 11
cohort studies (11) 11
hiv infection (11) 11
antiretroviral therapy, highly active (10) 10
microbiology (10) 10
sub-saharan africa (10) 10
article (9) 9
highly active antiretroviral therapy (9) 9
anti-hiv agents - administration & dosage (8) 8
antiviral agents (8) 8
care and treatment (8) 8
hiv infections - complications (8) 8
hiv-1 (8) 8
hiv/aids (8) 8
infected patients (8) 8
abridged index medicus (7) 7
africa (7) 7
aids (7) 7
dosage and administration (7) 7
patients (7) 7
research article (7) 7
treatment failure (7) 7
acquired immune deficiency syndrome--aids (6) 6
antiretroviral therapy, highly active - methods (6) 6
antitubercular agents - therapeutic use (6) 6
cd4 antigen (6) 6
drug resistance, viral (6) 6
hiv infections - immunology (6) 6
hiv patients (6) 6
hiv-1 - drug effects (6) 6
human immunodeficiency virus (6) 6
infection (6) 6
mutation (6) 6
south africa - epidemiology (6) 6
tuberculosis - drug therapy (6) 6
adolescent (5) 5
adults (5) 5
aids-related opportunistic infections - drug therapy (5) 5
analysis (5) 5
antiretroviral agents (5) 5
antiretrovirals (5) 5
drug administration schedule (5) 5
drug therapy, combination (5) 5
efavirenz (5) 5
failure (5) 5
hiv infections - mortality (5) 5
hiv-infected patients (5) 5
medicine (5) 5
multidisciplinary sciences (5) 5
pharmacokinetics (5) 5
protease inhibitors (5) 5
science (5) 5
tenofovir (5) 5
therapy (5) 5
virus diseases (5) 5
viruses (5) 5
young adult (5) 5
adherence (4) 4
aged (4) 4
anti-retroviral agents - administration & dosage (4) 4
benzoxazines - therapeutic use (4) 4
clinical trials (4) 4
diagnosis (4) 4
disease progression (4) 4
drug-resistance (4) 4
health aspects (4) 4
hiv 1 (4) 4
hiv infections - epidemiology (4) 4
hiv-1 - genetics (4) 4
impact (4) 4
infections (4) 4
medicine, general & internal (4) 4
nevirapine (4) 4
patient outcomes (4) 4
prospective studies (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9979, pp. 1738 - 1747
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 3/2010, Volume 201, Issue 6, pp. 803 - 813
Background. The MERIT (M̄araviroc versus Ēfavir̄enz īn T̄reatment-Naive Patients) study compared maraviroc and efavirenz, both with zidovudine-lamivudine, in... 
HIV/AIDS | Tropisms | RNA | HIV | Stock options | Response rates | Viruses | Infections | Post hoc | HIV 1 | Virology | INFECTIOUS DISEASES | EFFICACY | SAFETY | MICROBIOLOGY | HIV-1-INFECTED PATIENTS | IMMUNOLOGY | LOPINAVIR-RITONAVIR | THERAPY | VIROLOGICAL FAILURE | RESISTANT HIV-1 | INHIBITOR | CORECEPTOR TROPISM | PLUS | Anti-HIV Agents - pharmacology | Lamivudine - administration & dosage | Cyclohexanes - pharmacology | Humans | Middle Aged | Drug Resistance, Viral | Male | Anti-HIV Agents - standards | Viral Load | Zidovudine - administration & dosage | Young Adult | Cyclohexanes - therapeutic use | Receptors, CCR5 - metabolism | HIV-1 - physiology | Adult | Female | Triazoles - standards | Viral Tropism | Drug Therapy, Combination | CCR5 Receptor Antagonists | Triazoles - therapeutic use | Antiviral Agents - pharmacology | Double-Blind Method | HIV-1 - drug effects | Treatment Outcome | Anti-Retroviral Agents | Benzoxazines - standards | Benzoxazines - therapeutic use | Triazoles - pharmacology | Adolescent | Benzoxazines - pharmacology | Cyclohexanes - standards | HIV Infections - drug therapy | Aged | Drug Combinations | Maraviroc | Patient outcomes | Physiological aspects | Dosage and administration | Genetic aspects | Research | Drug therapy, Combination | Drug therapy | HIV infection | Efavirenz | Chemokines
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 4, pp. 307 - 317
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2011, Volume 365, Issue 16, pp. 1482 - 1491
Journal Article
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ISSN 1058-4838, 01/2018, Volume 66, Issue 1, pp. 159 - 159
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2012, Volume 54, Issue 11, pp. 1660 - 1669
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 8/2013, Volume 57, Issue 4, pp. 586 - 593
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2017, Volume 65, Issue 7, p. 1226
We retrospectively reviewed the Determine TB-LAM lateral flow assay (LF-LAM) results among human immunodeficiency virus-infected patients with disseminated... 
Tuberculosis | Human immunodeficiency virus--HIV | Bacteria | Viruses | Patients
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, p. e0161469
Background South African HIV treatment guidelines call for patients who fail first-line antiretroviral therapy (ART) to be switched to second-line ART, yet... 
VIRAL LOAD | MORTALITY | 1ST-LINE ANTIRETROVIRAL THERAPY | VIROLOGICAL FAILURE | MULTIDISCIPLINARY SCIENCES | INFECTED PATIENTS | ACCUMULATION | VIREMIA COPY-YEARS | ASSOCIATION | DRUG-RESISTANCE MUTATIONS | ADHERENCE | Drug Substitution - mortality | HIV Infections - virology | Humans | Proportional Hazards Models | Male | CD4 Lymphocyte Count | Viral Load | Patient Compliance - statistics & numerical data | Antiretroviral Therapy, Highly Active | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Time Factors | Treatment Failure | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - mortality | South Africa | Drug Substitution - statistics & numerical data | Patient Compliance - psychology | CD4-Positive T-Lymphocytes - virology | Cohort Studies | Antiviral agents | Care and treatment | Analysis | Practice guidelines (Medicine) | Health care industry | Dosage and administration | Management | HIV infection | Health care | Antiretroviral drugs | Mortality | Hazards | Drug resistance | Patients | Delay | Antiretroviral therapy | CD4 antigen | Structural models | Statistical models | Acquired immune deficiency syndrome--AIDS | Protease inhibitors | Antiretroviral agents | Human immunodeficiency virus--HIV | Failure analysis | Death | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Tropical Medicine & International Health, ISSN 1360-2276, 09/2016, Volume 21, Issue 9, pp. 1131 - 1137
Objective In resource‐limited settings, where genotypic drug resistance testing is rarely performed and poor adherence is the most common reason for treatment... 
antiretroviral therapy | tratamiento antirretroviral | fallo virológico | inhibiteur de protéase | inhibidor de proteasas | África subsahariana | échec virologique | virologic failure | HIV genotyping | treatment failure | fallo en el tratamiento | protease inhibitor | traitement antirétroviral de deuxième ligne | thérapie antirétrovirale | tratamiento antirretroviral de tercera línea | traitement antirétroviral de troisième ligne | tratamiento antirretroviral de segunda línea | second‐line antiretroviral therapy | Afrique subsaharienne | lopinavir | sub‐Saharan Africa | échec du traitement | genotipaje del VIH | third‐line antiretroviral therapy | génotypage du VIH | second-line antiretroviral therapy | sub-Saharan Africa | third-line antiretroviral therapy | TREATMENT OUTCOMES | TROPICAL MEDICINE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | COHORT | INCOME COUNTRIES | LIFE EXPECTANCY | HIV-1 | Prospective Studies | HIV Infections - virology | Humans | Middle Aged | Drug Resistance, Viral | Male | CD4 Lymphocyte Count | Viral Load | Antiretroviral Therapy, Highly Active | Treatment Failure | Counseling | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | South Africa | Patient Compliance | Highly active antiretroviral therapy | Protease inhibitors | Proteases | HIV patients | Drug resistance | HIV (Viruses) | HIV infection | Patient compliance | Studies | Drug therapy | Human immunodeficiency virus--HIV
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0158262
Journal Article